Hostname: page-component-76c49bb84f-887v8 Total loading time: 0 Render date: 2025-07-04T11:45:42.117Z Has data issue: false hasContentIssue false

Improving containment and prevention strategies using a patient transfer network representative of patients with multidrug-resistant organisms

Published online by Cambridge University Press:  23 June 2025

Rany Octaria*
Affiliation:
Vanderbilt Epidemiology Ph.D. Program, Vanderbilt University Graduate School, Nashville, TN, USA Healthcare-Associated Infections and Antimicrobial Resistance Program, Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, USA
Stephen Deppen
Affiliation:
Department of Thoracic Surgery and Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA
Allison Chan
Affiliation:
Healthcare-Associated Infections and Antimicrobial Resistance Program, Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, USA
James C. Slaughter
Affiliation:
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA
Pamela Talley
Affiliation:
HIV/STI/Viral Hepatitis Program, Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, USA
Rachel B. Slayton
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Peter F. Rebeiro
Affiliation:
Department of Medicine, Vanderbilt University, Nashville, TN, USA
Marion A. Kainer
Affiliation:
Healthcare-Associated Infections and Antimicrobial Resistance Program, Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, USA Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA
*
Corresponding author: Rany Octaria; Email: ranyoctaria@gmail.com

Abstract

Objectives:

Interfacility patient transfers contribute to the regional spread of multidrug-resistant organisms (MDROs). We evaluated whether transfer patterns of inpatients with similar characteristics to carbapenem-resistant Enterobacterales (CRE) case-patients (CRE surrogates) better reflect hospital-level CRE burden than traditionally used populations.

Design:

We determined the risk factors for subsequent hospital admission using demographic and clinical information from Tennessee Department of Health tracked CRE case-patients from July 2015 to September 2019. Risk factors were used to identify CRE surrogates among inpatients in the 2018 Tennessee Hospital Discharge Data System (HDDS). Transfer networks of CRE surrogates, Medicare/TennCare beneficiaries, and all-inpatients with ≤365 days of intervening community stays were compared with the transfer networks of CRE case-patients in 2019. The associations between hospital-level CRE prevalence and hospitals’ incoming transfer volumes from each network were assessed using negative binomial regression models.

Results:

Eight risk factors for subsequent hospital admission were identified from 2,518 CRE case-patients, which were used to match CRE case-patients with HDDS inpatients, resulting in 10,069 surrogate patients. CRE surrogate network showed more structural similarities with the CRE case-patient network than with the all-inpatient and Medicare/TennCare networks. A 33% increase in hospitals’ CRE prevalence in 2019 was associated with each doubling of incoming transfer of CRE surrogates in 2018 (adjusted Risk Ratio [aRR] 1.33, 95%CI: 1.1, 1.59), higher than all-inpatient (aRR 1.27, 95% CI: 1.08, 1.51) and Medicare/TennCare networks (aRR 1.21, 95% CI: 1.02, 1.44).

Conclusions:

Surrogate transfer patterns were associated with hospital-level CRE prevalence, highlighting their value in MDRO containment and prevention.

Information

Type
Original Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

a

Current affiliation: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.

b

Current affiliation: Infectious Diseases, Western Health, Footscray, Victoria, Australia.

References

Centers for Disease Control and Prevention. 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance.; 2022. Accessed July 14, 2022. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf Google Scholar
Johnston, KJ, Thorpe, KE, Jacob, JT, Murphy, DJ. The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting—A national estimate. Health Serv Res 2019;54:782792. doi: 10.1111/1475-6773.13135 CrossRefGoogle ScholarPubMed
Zimmerman, FS, Assous, MV, Bdolah-Abram, T, Lachish, T, Yinnon, AM, Wiener-Well, Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control 2013;41:190194. doi: 10.1016/j.ajic.2012.09.020 CrossRefGoogle ScholarPubMed
Haverkate, MR, Weiner, S, Lolans, K, et al. Duration of colonization with Klebsiella pneumoniae carbapenemase-producing bacteria at long-term acute care hospitals in Chicago, Illinois. Open Forum Infect Dis 2016;3:ofw178. doi: 10.1093/ofid/ofw178 CrossRefGoogle ScholarPubMed
Bar-Yoseph, H, Hussein, K, Braun, E, Paul, M. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother 2016;71:27292739. doi: 10.1093/jac/dkw221 CrossRefGoogle ScholarPubMed
Mo, Y, Hernandez-Koutoucheva, A, Musicha, P, et al. Duration of carbapenemase-producing enterobacteriaceae carriage in hospital patients. Emerg Infect Dis 2020;26:21822185. doi: 10.3201/eid2609.190592 CrossRefGoogle ScholarPubMed
Barnes, SL, Harris, AD, Golden, BL, Wasil, EA, Furuno, JP. Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels. Infect Control Hosp Epidemiol 2011;32:10731078. doi: 10.1086/662375 CrossRefGoogle ScholarPubMed
Donker, T, Wallinga, J, Slack, R, Grundmann, H. Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer. PloS One 2012;7. doi: 10.1371/journal.pone.0035002 CrossRefGoogle ScholarPubMed
Ray, MJ, Lin, MY, Weinstein, RA, Trick, WE. Spread of carbapenem-resistant Enterobacteriaceae among Illinois healthcare facilities: the role of patient sharing. Clin Infect Dis 2016;63:889893. doi: 10.1093/cid/ciw461 Google ScholarPubMed
Nekkab, N, Crépey, P, Astagneau, P, Opatowski, L, Temime, L. Assessing the role of interfacility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015. Sci Rep 2020;10:14940. doi: 10.1038/s41598-020-71212-6 CrossRefGoogle ScholarPubMed
Bower, CW, Fridkin, DW, Wolford, HM, et al. Evaluating movement of patients with carbapenem-resistant Enterobacteriaceae infections in the Greater Atlanta Metropolitan area using social network analysis. Clin Infect Dis 2020;70:7581. doi: 10.1093/cid/ciz154 Google ScholarPubMed
Lapp, Z, Octaria, R, O’Malley, SM, et al. Distinct origins and transmission pathways of blaKPC Enterobacterales across Three U.S. states. J Clin Microbiol 2023;61:e0025923. doi: 10.1128/jcm.00259-23 Google ScholarPubMed
Centers for Disease Control and Prevention. Public Health Strategies to Prevent the Spread of Novel and Targeted Multidrug-resistant Organisms (MDROs). Published online 2023. https://www.cdc.gov/hai/mdro-guides/index.html Google Scholar
Bhargava, A, Hayakawa, K, Silverman, E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients: exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014;35:398405. doi: 10.1086/675614 CrossRefGoogle ScholarPubMed
Guh, AY, Bulens, SN, Mu, Y, et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012-2013. JAMA - J Am Med Assoc 2015;314:14791487. doi: 10.1001/jama.2015.12480 CrossRefGoogle ScholarPubMed
Van Loon, K, Voor In’T Holt, AF, Vos, MC. A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant enterobacteriaceae. Antimicrob Agents Chemother 2017;62(1):e0173017. doi:10.1128/AAC.01730-17 Google ScholarPubMed
Kassem, A, Raed, A, Michael, T, et al. Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol 2020;41:11541161. doi: 10.1017/ice.2020.266 CrossRefGoogle ScholarPubMed
Council of State and Territorial Epidemiologists. Change in Case Definition from Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) to Carbapenemase-Producing Organisms (CPO), 2017. https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/ps2022/22-ID-04_CPO.pdf Google Scholar
Council of State and Territorial Epidemiologists. Standardized Definition for Carbapenem-Resistant Enterobacteriaceae (CRE) and Recommendation for Sub-Classification and Stratified Reporting.; 2015. Accessed June 9, 2021. https://cdn.ymaws.com/www.cste.org/resource/resmgr/2015PS/2015PSFinal/15-ID-05.pdf Google Scholar
Division of TennCare. Aged, Blind and Disabled Manual: Qualified Medicare Beneficiary. Published online March 8, 2024. https://www.tn.gov/content/dam/tn/tenncare/documents/QualifiedMedicareBeneficiary.pdf Google Scholar
Strengths and Limitations of CMS Administrative Data in Research | ResDAC. Accessed November 27, 2024. https://resdac.org/articles/strengths-and-limitations-cms-administrative-data-research Google Scholar
Feng, C, Wang, H, Lu, N, et al. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry 2014;26:105. doi: 10.3969/J.ISSN.1002-0829.2014.02.009 Google ScholarPubMed
Interpreting Log Transformations in a Linear Model | University of Virginia Library Research Data Services + Sciences. Accessed May 13, 2022. https://data.library.virginia.edu/interpreting-log-transformations-in-a-linear-model/ Google Scholar
Ladha, KS, Zhao, K, Quraishi, SA, et al. The Deyo-Charlson and Elixhauser-van Walraven comorbidity indices as predictors of mortality in critically ill patients. BMJ Open 2015;5:8990. doi: 10.1136/BMJOPEN-2015-008990 CrossRefGoogle ScholarPubMed
Wolford, H, O’Hagan, J, Paul, P, et al. Comparing inter-hospital patient movement patterns to better understand mechanisms for regional dissemination of carbapenem-resistant Enterobacteriaceae. Open Forum Infect Dis 2019;6:S859. doi: 10.1093/OFID/OFZ360.2159 CrossRefGoogle Scholar
Weiner-Lastinger, LM, Pattabiraman, V, Konnor, RY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2022;43:1225. doi: 10.1017/ICE.2021.362 CrossRefGoogle Scholar
Cybersecurity & Infrastructure Security Agency. Healthcare and Public Health Sector. Accessed May 26, 2022. https://www.cisa.gov/healthcare-and-public-health-sector Google Scholar
French, G, Hulse, M, Nguyen, D, et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic — United States, July 2020–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:16131616. doi: 10.15585/MMWR.MM7046A5 CrossRefGoogle Scholar
Ray, MJ, Lin, MY, Tang, AS, et al. Regional spread of an outbreak of carbapenem-resistant enterobacteriaceae through an ego network of healthcare facilities. Clin Infect Dis 2018;67:407410. doi: 10.1093/cid/ciy084 CrossRefGoogle ScholarPubMed
Slayton, RB, Toth, D, Lee, BY, et al. Vital signs: Estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities - United States. Am J Transplant 2015;15:30023007. doi: 10.1111/ajt.13555 CrossRefGoogle Scholar
Cincotta, SE, Walters, MS, Ham, DC, et al. Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: A modeling study. Infect Control Hosp Epidemiol. 2024;45(7):856863. doi: 10.1017/ice.2023.278 CrossRefGoogle ScholarPubMed
Octaria, R, Cincotta, S, Healy, J, et al. An interactive patient transfer network and model visualization tool for multidrug-resistant organism prevention strategies. Antimicrob Steward Healthc Epidemiol ASHE 2023;3:s120s122. doi: 10.1017/ash.2023.403 Google Scholar
Lee, BY, Bartsch, SM, Wong, KF, et al. Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated. Infect Control Hosp Epidemiol 2019;40:731734. doi: 10.1017/ice.2019.61 CrossRefGoogle ScholarPubMed
Mckinnell, JA, Singh, RD, Miller, LG, et al. The SHIELD orange county project: multidrug-resistant organism prevalence in 21 nursing homes and long-term acute care facilities in Southern California. Clin Infect Dis 2019;69:15661573. doi: 10.1093/cid/ciz119 CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256260.Google Scholar
Michelson, KA, Rees, CA, Sarathy, J, et al. Interregional transfers for pandemic surges. Clin Infect Dis 2021;73:e4103e4110. doi: 10.1093/CID/CIAA1549 CrossRefGoogle ScholarPubMed
Jackson, MO. Social and Economic Networks. Princeton University Press; 2008.10.1515/9781400833993CrossRefGoogle Scholar
Hansen, DL, Shneiderman, B, Smith, MA, Himelboim, I. Installation, orientation, and layout. Anal Soc Media Netw NodeXL Insights Connect World. Published online January 1, 2019:55-66. doi: 10.1016/B978-0-12-817756-3.00004-2 CrossRefGoogle Scholar
Supplementary material: File

Octaria et al. supplementary material

Octaria et al. supplementary material
Download Octaria et al. supplementary material(File)
File 161.9 KB